Vivek Subbiah, MD

Dr Vivek Subbiah | Image Credit: TargetCancer Foundation

Vivek Subbiah, MD, is the chief of early-phase drug development at Sarah Cannon Research Institute.

Articles by Vivek Subbiah, MD

Latest Updated Articles



    Brand Logo

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    © 2025 MJH Life Sciences®

    All rights reserved.

    Secondary Brand Logo